Catalyst Wire Dossier Catalyst Wire Dossier

Ensifentrine

ensifentrine · Verona Pharma plc
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Ensifentrine, covering 2022-09-22 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD [Phase 2]

See pricing